Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | APLNR | P35414 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 3/20 | 0.34 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA9 | Q16790 | 2/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | PGK1 | P00558 | 1/20 | 0.33 |
| ▸ | PGK2 | P07205 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 3/20 | 0.32 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.32 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4202727 | 0.81 | TDP1 (0.48) | TDP1MAOAMAOBMEN1GAA | |
| SCHEMBL15792134 | 0.78 | MEN1 (0.33) | MEN1GAAKMT2ALMNAPOLB | |
| SCHEMBL17212001 | 0.77 | CA2 (0.50) | TDP1MAOAMAOBMEN1GAA | |
| SCHEMBL62352 | 0.77 | TDP1 (0.42) | TDP1MAOAMAOBMEN1GAA | |
| SCHEMBL17211116 | 0.77 | TDP1 (0.42) | TDP1MAOAMAOBMEN1GAA | |
| SCHEMBL28918296 | 0.75 | APLNR (0.40) | TDP1MEN1GAAKMT2AAPLNR | |
| SCHEMBL22991709 | 0.74 | KDM4C (0.41) | MEN1KMT2ALMNAPOLBPGK1 | |
| SCHEMBL1289840 | 0.74 | TDP1 (0.42) | TDP1MAOAMAOBMEN1GAA | |
| SCHEMBL15792091 | 0.74 | LMNA (0.49) | TDP1MAOAMAOBMEN1GAA | |
| SCHEMBL4449244 | 0.74 | TDP1 (0.36) | TDP1MEN1GAAKMT2AAPLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025022883-A1 | METHOD FOR PRODUCING AMIDE COMPOUND | 日本曹達株式会社 | 2025-01-30 | — | — | WO | disclosed |
| EP-3778563-B1 | PHENOXYUREA COMPOUND AND PEST CONTROL AGENT | NIPPON SODA CO (JP) | 2024-05-29 | — | — | EP | disclosed |
| US-11044911-B2 | Phenoxyurea compound and pest control agent | NIPPON SODA CO., LTD. (JP) | 2021-06-29 | — | — | US | disclosed |
| US-20210051960-A1 | PHENOXYUREA COMPOUND AND PEST CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2021-02-25 | — | — | US | disclosed |
| WO-2019198592-A1 | PHENOXYUREA COMPOUND AND PEST CONTROL AGENT | 日本曹達株式会社 | 2019-10-17 | — | — | WO | disclosed |
| EP-3491922-A1 | PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO | Dow AgroSciences LLC (US) | 2019-06-05 | — | — | EP | disclosed |
| US-20170158675-A1 | PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO | DOW AGROSCIENCES LLC (US) | 2017-06-08 | — | — | US | disclosed |
| US-9622477-B2 | Pesticidal compositions and processes related thereto | DOW AGROSCIENCES LLC (US) | 2017-04-18 | — | — | US | disclosed |
| US-9538756-B2 | Pesticidal compositions and processes related thereto | DOW AGROSCIENCES LLC (US) | 2017-01-10 | — | — | US | disclosed |
| US-20160044925-A1 | PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO | DOW AGROSCIENCES LLC (US) | 2016-02-18 | — | — | US | disclosed |
| EP-2532667-A1 | Deazapurines useful as inhibitors of janus kinases | Vertex Pharmaceuticals Incorporated (US) | 2012-12-12 | — | — | EP | disclosed |
| EP-1931674-B1 | DEAZAPURINES USEFUL AS INHIBITORS OF JANUS KINASES | VERTEX PHARMA (US) | 2012-12-12 | — | — | EP | disclosed |
| US-20120165307-A1 | AZAINDOLES USEFUL AS INHIBITORS OF JANUS KINASES | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2012-06-28 | — | — | US | disclosed |
| US-8163917-B2 | Azaindoles useful as inhibitors of Janus kinases | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2012-04-24 | — | — | US | disclosed |
| US-20100311743-A1 | Azaindoles Useful as Inhibitors of Janus Kinases | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2010-12-09 | — | — | US | disclosed |
| US-7767816-B2 | for treating proliferative disorders, cardiac disorders, neurodegenerative disorders, autoimmune disorders, conditions associated with organ transplantation, inflammatory disorders, and/or immunologically mediated disorders | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2010-08-03 | — | — | US | disclosed |
| EP-1973911-A2 | AZAINDOLES USEFUL AS INHIBITORS OF JANUS KINASES | Vertex Pharmaceuticals, Inc. (US) | 2008-10-01 | — | — | EP | disclosed |
| US-20070207995-A1 | Deazapurines useful as inhibitors of Janus kinases | VERTEX PHARMACEUTICALS INCORPORATED | 2007-09-06 | — | — | US | disclosed |
| US-20070203142-A1 | for treating proliferative disorders, cardiac disorders, neurodegenerative disorders, autoimmune disorders, conditions associated with organ transplantation, inflammatory disorders, and/or immunologically mediated disorders | VERTEX PHARMACEUTICALS INCORPORATED | 2007-08-30 | — | — | US | disclosed |
| WO-2007084557-A2 | AZAINDOLES USEFUL AS INHIBITORS OF JANUS KINASES | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2007-07-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203142-A1 | for treating proliferative disorders, cardiac disorders, neurodegenerative disorders, autoimmune disorders, conditions associated with organ transplantation, inflammatory disorders, and/or immunologically mediated disorders | JAK1, JAK3, MYLK2 | TDP1 406/4885MAOA 3304/4885MAOB 2627/4885 |
| US-20120165307-A1 | AZAINDOLES USEFUL AS INHIBITORS OF JANUS KINASES | JAK3, JAK1, JAK2 | TDP1 1359/4885MAOA 1649/4885MAOB 1816/4885 |
| US-20100311743-A1 | Azaindoles Useful as Inhibitors of Janus Kinases | JAK3, JAK1, JAK2 | TDP1 1359/4885MAOA 1649/4885MAOB 1816/4885 |
| US-20210051960-A1 | PHENOXYUREA COMPOUND AND PEST CONTROL AGENT | H1-0, H1-4, H1-3 | TDP1 3466/4885MAOA 3375/4885MAOB 3077/4885 |
| US-20160044925-A1 | PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO | ACHE, DDT, PTMS | TDP1 2276/4885MAOA 699/4885MAOB 1013/4885 |
| US-20170158675-A1 | PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO | ACHE, DDT, PTMS | TDP1 2276/4885MAOA 699/4885MAOB 1013/4885 |
| US-20070207995-A1 | Deazapurines useful as inhibitors of Janus kinases | JAK1, JAK3, JAK2 | TDP1 539/4885MAOA 3049/4885MAOB 2722/4885 |
| US-11044911-B2 | Phenoxyurea compound and pest control agent | H1-0, H1-4, H1-3 | TDP1 3466/4885MAOA 3375/4885MAOB 3077/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.